Mar 4, 26BUYButler John P.· CEO and President69,270 sh @ $1.25$87K↗
Feb 2, 26SELLButler John P.· CEO and President114,891 sh @ $1.39−$160K↗
Feb 2, 26SELLButler John P.· CEO and President96,065 sh @ $1.39−$134K↗
Feb 2, 26SELLButler John P.· CEO and President83,689 sh @ $1.39−$116K↗
Feb 2, 26SELLGrund Nicholas· Chief Commercial Officer53,585 sh @ $1.39−$74K↗
Feb 2, 26SELLButler John P.· CEO and President46,660 sh @ $1.39−$65K↗
Feb 2, 26SELLMalabre Richard C· SVP, Chief Accounting Officer36,142 sh @ $1.39−$50K↗
Feb 2, 26SELLOstrowski Erik· SVP, CFO, CBO & Treasurer34,951 sh @ $1.39−$49K↗
Feb 2, 26SELLGrund Nicholas· Chief Commercial Officer31,244 sh @ $1.39−$43K↗
Feb 2, 26SELLRucci Carolyn M.· SVP, Chief Legal Officer27,544 sh @ $1.39−$38K↗
Feb 2, 26SELLRucci Carolyn M.· SVP, Chief Legal Officer25,382 sh @ $1.39−$35K↗
Feb 2, 26SELLBurke Steven Keith· SVP, Chief Medical Officer25,375 sh @ $1.39−$35K↗
Feb 2, 26SELLBurke Steven Keith· SVP, Chief Medical Officer21,582 sh @ $1.39−$30K↗
Feb 2, 26SELLBurke Steven Keith· SVP, Chief Medical Officer20,701 sh @ $1.39−$29K↗
Feb 2, 26SELLRucci Carolyn M.· SVP, Chief Legal Officer16,846 sh @ $1.39−$23K↗
Feb 2, 26SELLMalabre Richard C· SVP, Chief Accounting Officer13,382 sh @ $1.39−$19K↗

routine RSU / option mechanics (4)

Data sources

last refreshed 51m ago

Found something off?

$AKBA1.2900+4.03%

$AKBAAkebia Therapeutics, Inc.

Pipeline(4)